Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126968751 | 12696875 | 1 | I | 20160825 | 0 | 20160829 | 20160829 | DIR | 83.00 | YR | F | N | 110.00000 | LBS | 20160826 | N | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126968751 | 12696875 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 1 TABLET IN THE MORNING | Y | Y | 0 | 1 | DF | COATED TABLET | |||||
126968751 | 12696875 | 3 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | 0 | ||||||||||||
126968751 | 12696875 | 5 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
126968751 | 12696875 | 7 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126968751 | 12696875 | 1 | Depression |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126968751 | 12696875 | Asthenia | |
126968751 | 12696875 | Dizziness | |
126968751 | 12696875 | Fatigue | |
126968751 | 12696875 | Headache | |
126968751 | 12696875 | Influenza | |
126968751 | 12696875 | Malaise | |
126968751 | 12696875 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126968751 | 12696875 | 1 | 1 | DAY |